Innovate UK x ATMP Flemingsberg: Collaborations, Inspiration, and Networking

At the beginning of the year, we had the privilege of welcoming a delegation from England, with representatives from Innovate UK and eleven ATMP (Advanced Therapy Medicinal Products) companies. This marks the beginning of a significant partnership with great potential to ultimately cure diseases that were previously incurable.

ATMP Flemingsberg
It was an intense morning that began with a presentation of the new initiative ATMP Flemingsberg. Flemingsberg is more than just a location; it’s a hub where expertise, innovation, and collaboration seamlessly come together. This unique environment is characterized by its close proximity, the growing city, and of course the Karolinska ATMP center, which brings together world-leading research, the hospital and cutting-edge research facilities.

– The visit from Innovate UK was very successful. We and the companies and research infrastructures within ATMP in Flemingsberg had a unique opportunity to meet companies from England and listen to interesting business ideas and discuss future collaborations. The event also shows the fantastic ecosystem in the field that exists in Flemingsberg, which our visitors also testify to! Now we from the foundation are following up with our companies how we can take this further and see how we can create a structure for long-term cooperation with Innovate UK, says Johnny Högberg CEO of Flemingsberg Science Foundation.

An Ecosystem for Innovation
Flemingsberg-based companies XNK Therapeutics and Biomedrex took the stage to share their journeys, emphasizing how the vibrant atmosphere of Flemingsberg played a crucial role in their success stories. The synergy between the hospital, academia, and research institutes at the heart of Flemingsberg creates an exceptional ecosystem for innovation.

The day also included a pitching session that provided a platform for both British and local companies to showcase their visions. This not only fostered a deeper understanding of each other’s capabilities but also paved the way for potential collaborations in the future. This exchange laid the groundwork for future partnerships, knowledge exchange, and breakthroughs in the field of advanced therapies. We look forward to taking the next step in this partnership.

OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg

Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on the Flemingsberg Campus. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.

Drivhuset Stockholm – Where Future Entrepreneurs Take Their First Steps

Imagine a place where young ideas are free to grow, where passion meets ambition, and where the entrepreneurs of tomorrow take their first steps toward greatness. That’s exactly what Drivhuset Stockholm offers – a springboard for the next generation of entrepreneurs. Located on Campus Flemingsberg, we support students every day as they bring their ideas to life and build the skills needed to create real change. Our mission? To provide them with a safe, inspiring environment where they can test and develop their business ideas for real.

Hitchhiker’s Guide to Startup Success: Mastering the Art of the Perfect Pitch

Earlier this fall, we launched the first event in our seminar series, Hitchhiker’s Guide to Startup Success, which we are organizing together with Miltenyi Biotec. The inaugural session featured an inspiring workshop led by pitch expert and coach Malcolm Larri. The event gathered innovators and entrepreneurs in the Life Sciences sector, with a particular focus on Advanced Therapy Medicinal Products (ATMP)—a rapidly growing field with tremendous potential to revolutionize healthcare.

Previous 202122 Next